ICC Labs
About ICC Labs
ICC Labs is a Uruguayan cannabis company acquired by Tilray. It was one of the first licensed producers in Uruguay and serves both the domestic and international markets.
Key Facts
- 1Acquired by Tilray/Aphria making it part of a global cannabis company
- 2One of Uruguay's first licensed commercial cannabis producers
Latest News
Tilray Accelerates Medical Cannabis Expansion Despite Sector Headwinds
TLRY pushes international medical platform growth as cannabis stocks face regulatory uncertainty and market volatility
Tilray's Panama Push Tests International Cannabis Expansion Strategy
TLRY explores Central American operations as cannabis companies seek growth beyond saturated North American markets amid regulatory headwinds.
Tilray Stock Eyes Inflection Point as Cannabis Markets Shift
TLRY approaches critical juncture amid evolving regulatory landscape and operational restructuring efforts across North American cannabis markets.
TLRY Diversifies Beyond Cannabis With Craft Beverage Expansion
Tilray Brands leverages dual-market strategy combining cannabis operations with craft beverage acquisitions to drive revenue growth and market expansion.
Tilray Positioned for US Cannabis Rescheduling Windfall
TLRY stock could surge as federal rescheduling opens massive US market opportunities for the Canadian cannabis giant's established operations.
Frequently Asked Questions
Who owns ICC Labs?
ICC Labs was acquired by Aphria (now Tilray) and operates as part of Tilray's Latin American operations.
What products does ICC Labs produce?
ICC Labs produces cannabis flowers for the Uruguayan market and hemp-derived CBD products for export.
More Cannabis Companies in Montevideo
Products
- Cannabis flowers
- Hemp CBD products
- Cannabis extracts
Specialties
Company Details
- Location
- Montevideo, Uruguay
- Founded
- 2017
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY